Search research articles
Contact Us
Filters
Showing results (131-140 of 187) with videos related to
Page
of 19
Sort By:
JCO Precision Oncology
|
December 27, 2021
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring <i>MET</i> Exon 14 Skipping
Xiuning Le, Lingzhi Hong, Chuck Hensel, et al.
The Oncologist
|
August 28, 2020
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series
Jacques Cadranel, Stephen V Liu, Michaël Duruisseaux, et al.
Journal of Neuroimmunology
|
October 12, 2016
Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4
Mario A Pulido, Meleeneh Kazarian DerHartunian, Zhenxia Qin, et al.
American Journal of Clinical Oncology
|
February 21, 2018
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study
Roger B Cohen, Jean-Pierre Delord, Toshihiko Doi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
Stephen V Liu, Martin Reck, Aaron S Mansfield, et al.
Cancer
|
February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities
Sonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Clinical Lung Cancer
|
November 21, 2021
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer
Misako Nagasaka, Vijendra Singh, Yasmine Baca, et al.
Cancer Cell
|
November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
American Journal of Hematology
|
August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support
Dan T Vogl, Stephen V Liu, Elise A Chong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2024
A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies
Sarina Piha-Paul, Shane A Olwill, Erika Hamilton, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 187) with videos related to
Sort By:
Page
of 19
JCO Precision Oncology
|
December 27, 2021
Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring <i>MET</i> Exon 14 Skipping
Xiuning Le, Lingzhi Hong, Chuck Hensel, et al.
The Oncologist
|
August 28, 2020
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series
Jacques Cadranel, Stephen V Liu, Michaël Duruisseaux, et al.
Journal of Neuroimmunology
|
October 12, 2016
Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4
Mario A Pulido, Meleeneh Kazarian DerHartunian, Zhenxia Qin, et al.
American Journal of Clinical Oncology
|
February 21, 2018
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study
Roger B Cohen, Jean-Pierre Delord, Toshihiko Doi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2021
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
Stephen V Liu, Martin Reck, Aaron S Mansfield, et al.
Cancer
|
February 28, 2026
Multiomic characterization of small cell lung cancer: Real-world insights into therapeutic opportunities
Sonam Puri, Andrew Elliott, Abdul Rafeh Naqash, et al.
Clinical Lung Cancer
|
November 21, 2021
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer
Misako Nagasaka, Vijendra Singh, Yasmine Baca, et al.
Cancer Cell
|
November 22, 2024
Mutation burden and anti-PD-1 outcomes are not universally associated with immune cell infiltration or lymphoid activation
David Hsiehchen, Andrew Elliott, Joanne Xiu, et al.
American Journal of Hematology
|
August 19, 2007
Post-transplant outcomes of induction therapy for myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphalan with autologous stem cell support
Dan T Vogl, Stephen V Liu, Elise A Chong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2024
A First-in-Human Study of Cinrebafusp Alfa, a HER2/4-1BB Bispecific Molecule, in Patients with HER2-Positive Advanced Solid Malignancies
Sarina Piha-Paul, Shane A Olwill, Erika Hamilton, et al.
Page
of 19